Caricamento...
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
Therapeutic factor VIII is highly immunogenic. Despite intensive research in the last decades, the reasons why 5-30% of patients with hemophilia A (of all severities) develop inhibitory anti-factor VIII antibodies (inhibitors) following replacement therapy remain an enigma. Under physiological condi...
Salvato in:
| Pubblicato in: | Haematologica |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ferrata Storti Foundation
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355482/ https://ncbi.nlm.nih.gov/pubmed/30514798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.206383 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|